Skip to content
Tenfell
Awarded contract
Published 01 Oct 2018

NHS England Framework Agreement: South of England (Tranche B)

NHS England · London

Key facts

Awarded
13 Sep 2018
Contract starts
31 Aug 2018
Contract ends
31 Aug 2020
Procedure
Open procedure (above threshold)
Buyer type
Central government

Awarded to 32 suppliers

SupplierValue
Takeda UK Limited—
Aventis Pharma Ltd Trading As Sanofi—
Janssen-Cilag Ltd—
Pfizer Ltd—
Teva UK Ltd—
Bayer plc—
MSD—
Napp Pharmaceuticals—
Sandoz Ltd—
Biogen—
Eli Lilly & Company Ltd—
Gedeon Richter UK Ltd—
Gilead Sciences Limited—
Ipsen—
Novartis Pharmaceuticals UK Ltd—
Novo Nordisk—
Roche Products Ltd—
UCB Pharma Ltd—
Intrapharm Laboratories Ltd—
Ferring Pharmaceuticals Limited—
LEO Pharma Ltd—
Bristol-Myers Squibb Pharmaceuticals Ltd—
Chiesi Limited—
ROVI Biotech Ltd—
Boehringer Ingelheim—
Astellas Pharma Ltd—
Pharmasure—
Daiichi Sankyo UK Ltd—
Genzyme Therapeutics Ltd—
Merck—
Generics [UK] ta Mylan—
Abacus Medicine A/S—

Description

Contracts finder - award notice

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.